The Incidence of Thyroid Cancer in England and Wales over A Ten-Year Period

Main Article Content

Louise Marie Evans
Michael Stechman
David Owens

Abstract

Introduction


The incidence of thyroid cancer has increased worldwide, whether a real or apparent increase is debated. Literature from the USA suggests greater diagnostic scrutiny, environmental and genetic factors may all play a part. This increase will result in a greater number of referrals for surgical assessment. This study examined the trend in incidence of thyroid cancer in England and Wales.


Materials and Methods


A retrospective study, using the HES database over the period 2000-2010. Data were extracted of all newly diagnosed thyroid cancers in England and Wales and the age at diagnosis. Data were examined for the change in incidence of thyroid cancer diagnosis dependent on the age group of the patient using the linear regression model.


Results


45411 patients were identified. In England the incidence of thyroid cancer rose from 5.7/100,000 of the population in 2000 to 9.9/100,000 in 2010 and in Wales it rose from 3.5/100,000 in 2000 to 7.5/100,000. There was a statistical increase (P≤0.02) (t-stat >2) in the diagnosis of thyroid cancers across all age groups with exception of the 0-14 age group (P>0.5). 


Conclusion


There has been a statistical increase in the incidence of thyroid cancer. This is likely to impact on hospitals and cancer service resources. An increase in surgical demand and the coinciding ageing population highlights the importance of further investigation into the etiology, use of imaging, patient demographics, histology and overall mortality of this patient group.

Article Details

How to Cite
1.
Evans LM, Stechman M, Owens D. The Incidence of Thyroid Cancer in England and Wales over A Ten-Year Period. BJOHNS [Internet]. 2017Apr.30 [cited 2024Nov.23];25(1):8-11. Available from: https://bjohns.in/journal3/index.php/bjohns/article/view/103
Section
Main article
Author Biographies

Louise Marie Evans, Morriston Hospital Swansea Wales UK

ENT DEPT

Michael Stechman

Consultant General and Endocrine Surgeon

Endocrine Surgery

University Hospital of Wales Cardiff

David Owens

Consultant Otolaryngologist

University Hospital of Wales Cardiff

References

Reynolds RM, Weir J, Stockton DL et al. Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol (Oxf). 2005; 62(2): 156-62

Davies L, Welsh HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295(18): 2164-7

Albores-Saavedra J, Henson DE, Glazer E et al. Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype--papillary, follicular, and anaplastic: a morphological and epidemiological study. Endocr Pathol. 2007 Spring; 18(1): 1-7

Levi F, Franceschi S, Gulie C et al. Female thyroid cancer: the role of reproductive and hormonal factors in Switzerland. Oncology 1993; 50(4): 309-15

Franceschi S, Fassina A, Talamini R et al. The influence of reproductive and hormonal factors on thyroid cancer in women. Rev Epidemiol Sante Publique 1990; 38(1): 27-34

dos Santos Silva I, Swerdlow AJ. Thyroid cancer epidemiology in England and Wales: time trends and geographical distribution. Br J Cancer 1993; 67(2): 330-40

Oxford Cancer Intelligence Unit. Profile of Head and Neck Cancers in England. Incidence, Mortality and Survival.

Campbell SE, Campbell MK, Grimshaw JM et al. A systematic review of discharge coding accuracy. J Public Health 2001; 23: 205–11

Burns, EM, Rigby E, Mamidanna R, et al. Systematic review of discharge coding accuracy. J Public Health 2012 34 (1): 138-48

Amphlett B, Lawson Z, Abdulrahman GO Jr et al. Recent Trends in the Incidence, Geographical Distribution, and Survival From Thyroid Cancer in Wales, 1985-2010. Thyroid 2013 June

Mack WJ, Preston-Martin S, Bernstein L et al. Reproductive and Hormonal Risk Factors for Thyroid Cancer in Los Angeles County Females. Cancer Epidemiol Biomarkers Prev. 1999; 8(11):991-7

Guay B, Johnson-Obaseki SE, McDonald JT et al. Incidence of Differentiated Thyroid Cancer by Socioeconomic Status and Urban residence: Canada 1991-2006. Thyroid. 2013 Sep 4

Siu S, McDonald JT, Rajaraman M et al. Is lower socioeconomic status associated with more advanced thyroid cancer stage at presentation? A study in two Canadian centers.Thyroid. 2013 Sep 10

Ernest L. Mazzaferri, MD. Managing Small Thyroid Cancers.

JAMA 2006; 295(18): 2179-82

Boltz MM, Hollenbeak CS, Schaefer E et al. Attributable costs of differentiated thyroid cancer in the elderly Medicare population.

Surgery. 2013 Aug 22. Pii: S0039-6060 (13) 00364-4.

Office for National Statistics. March 2012. Population ageing in the United Kingdom, its Constituent Countries and the European Union. http://www.ons.gov.uk/ons/dcp171776_258607.pdf